Israël - hébreu - Ministry of Health

rafa laboratories ltd - letrozole 2.5 mg - film coated tablets - letrozole - letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Israël - hébreu - Ministry of Health

a.l. medi-market ltd. - metamizole sodium monohydrate - תמיסה להזרקה - metamizole sodium monohydrate 500 mg / 1 ml - metamizole sodium

Israël - hébreu - Ministry of Health

rafa laboratories ltd - omeprazole - קפסולות - omeprazole 40 mg - omeprazole

Israël - hébreu - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole

Israël - hébreu - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - קפסולה קשיחה - esomeprazole as sodium 20 mg - esomeprazole

Israël - hébreu - Ministry of Health

a.l. medi-market ltd. - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole

Israël - hébreu - Ministry of Health

perrigo israel agencies ltd - letrozole 2.5 mg - film coated tablets - letrozole - • femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .

Israël - hébreu - Ministry of Health

inovamed ltd - letrozole 2.5 mg - film coated tablets - letrozole - for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy.adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Israël - hébreu - Ministry of Health

taro international ltd - anastrozole 1 mg - tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Israël - hébreu - Ministry of Health

sam-on ltd - anastrozole 1 mg - film coated tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.